MedRegen LLC
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| MRG-001 in Patients With Amyotrophic Lateral Sclerosis (NCT06315608) | MedRegen LLC | 2025-07-01 |
| MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients (NCT06308926) | MedRegen LLC | 2024-12-01 |
| MRG-001 in Patients With Alcoholic Hepatitis (NCT06307522) | MedRegen LLC | 2024-09-01 |
| MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients (NCT04646603) | MedRegen LLC | 2021-12-01 |
Track MedRegen LLC automatically
Every clearance here is in the API, with alerts when new ones post.